Press Releases
Abbott receives FDA authorization for world’s first dual glucose-ketone sensing technology for people with diabetes ABBOTT PARK, Ill., Aug. 25, 2026 /PRNewswire/ — Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) authorization of its Libre Duo 10 Day system, the world’s first dual glucose‑ketone sensing technology. The new biowearable is designed […]
